← Back to headlines
Personalized mRNA Vaccine Shows Promise in Treating Skin Cancer
A personalized mRNA vaccine, when combined with immunotherapy, has shown promising long-term results in reducing the risk of melanoma recurrence, though it awaits approval and is expected to be expensive.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
